By Rick Nauert PhD Senior News Editor
Reviewed by John M. Grohol, Psy.D.on May 18, 2011
For decades, scientists have searched for a biologically-based test to predict who may be at risk for psychosis. Pencil-and-paper, behavioral tests already exist for the disorder.
One strategy looks at abnormal physiological findings of people with schizophrenia and then reviews the abnormalities to see if they can be used as a diagnostic or prognostic tool to help predict risk for developing the illness.
German and Swiss researchers took this approach in a study published in the journal Biological Psychiatry.
They used electroencephalography (EEG), which measures the brain’s electrical activity, or brain waves, to study the brain’s response to commonly and rarely presented tones that differed in length.
When these rare “deviant” tones are presented to healthy people, the brain automatically generates a particular electrical wave called mismatch negativity, or MMN. People diagnosed with schizophrenia have reduced MMN.
In the current study, researchers followed a group of people clinically at high risk for developing psychosis. They found that the individuals who went on to develop schizophrenia had smaller MMN than the subgroup who did not.
This finding suggests that MMN might be useful in predicting the later development of schizophrenia.
Although the results of the study are positive, researchers say they need to take a closer look.
“With this type of study, the devil is always in the details. How sensitive is MMN as a risk predictor? How reliable is it? How many people are mistakenly classified? How long of a follow-up period is necessary to make this test useful? Are there subgroups of individuals for whom this test is or is not reliable?” asked Dr. John Krystal, Editor of Biological Psychiatry.
“If we hope to use this type of measure to guide research and even clinical interventions, then it has to be an extremely robust measure with respect to the issues that I just mentioned, among others. Yet, this is exactly the type of initial step that we need to move toward clinically meaningful biological tests.”
Study author Dr. Mitja Bodatsch agreed, adding that “integration of both biological and clinical measures into multidimensional models might be the crucial next step forward to improve risk staging in psychiatry.”
Source: Elsevier
Related News Articles
-->Related Clinical Articles
-->
Brain and Behavior, General, Health-related, LifeHelper, Memory and Perception, Mental Health and Wellness, Neuropsychology and Neurology, Professional, Psychology, Psychotherapy, Research, Schizophrenia -->
« News Index
SchizophreniaOverview of SchizophreniaSchizophrenia Quick Fact Sheet Schizophrenia Screening Quiz An Introduction to SchizophreniaSchizophrenia SymptomsTypes of SchizophreniaTreatment OverviewSchizophrenia TreatmentLiving with Schizophrenia 13 Schizophrenia MythsTaking Medications for SchizophreniaSide Effects of MedicationsWhat Family Members Need to KnowSchizophrenia and Substance AbuseSchizophrenia and ViolenceWhat Causes Schizophrenia?When Someone Has Schizophrenia Related TopicsSchizophrenia NewsClinical TrialsResearchDSM Codes for Schizophrenia Recommended ResourcesBooksWebsites & Organizations Connect with OthersJoin Our Support GroupRate 'n Review Schizophrenia MedicationsLatest ArticlesPsychiatric Tales: Eleven Graphic Stories About Mental IllnessMy Schizophrenic Life: The Road to Recovery from Mental IllnessThe Health Impact of Regular Marijuana UseSchizophrenia for DummiesAfter Her Brain Broke: Helping My Daughter Recover Her SanityApproaching Neverland: A Memoir of Epic Tragedy & Happily Ever After
Just Published...Am I a Defensive Pessimist?Mindful Loving5 Ways to Silence Your Inner CriticYour Brain, Mindful Presence and Five Practices to Energize...
What's HotAPA Mental Health Blog Party 2011 Roundup
Find a Therapist
Users Online: 3148
Join Us Now!
Local GuidesAll Guides
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
DC
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Privacy Policy Terms of Use Site Map Disclaimer/Disclosure Feeds
Site last updated: 22 May 2011 Psych Central Professional
Psych Central Answers
Psych Central Blog Network
Psych Central News
Tests & Quizzes
Sanity Score
Forums NeuroTalk
ADHD
Anxiety
Bipolar
Depression
Schizophrenia
Psychotherapy
with the
HONcode
standard:
Verify here
0 comments:
Post a Comment